Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
05/21/1991 | US5017688 Peptides involved in the pathogenesis of HIV infection |
05/21/1991 | US5017565 Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase |
05/21/1991 | US5017489 Antibodies |
05/21/1991 | US5017372 Method of producing antibody-fortified dry whey |
05/18/1991 | WO1991007500A1 Specific binding agents |
05/18/1991 | WO1991007490A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2135744A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2068728A1 Protein complexes having factor viii:c activity and production thereof |
05/18/1991 | CA2066670A1 Specific binding agents |
05/16/1991 | WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/16/1991 | WO1991006861A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
05/16/1991 | WO1991006858A1 Novel monoclonal antibody against human platelets |
05/16/1991 | WO1991006668A1 Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity |
05/16/1991 | WO1991006664A1 Method for synthesizing adenosine phosphate derivatives and derivatives thereby obtained |
05/16/1991 | WO1991006655A1 E. coli secretory strains |
05/16/1991 | WO1991006648A1 Glutamate receptor compositions and methods |
05/16/1991 | WO1991006639A1 Recombinant production of lactoperoxidase |
05/16/1991 | WO1991006633A1 Differential diagnostic assay for brucellosis |
05/16/1991 | WO1991006632A1 Inhibition of padgem-mediated cell binding |
05/16/1991 | WO1991006575A1 Hiv-1 specific human monoclonal antibody |
05/16/1991 | WO1991006574A1 A process for preparing peroxycarboxylic acids |
05/16/1991 | WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
05/16/1991 | WO1991006570A1 HYBRID Fc RECEPTOR MOLECULES |
05/16/1991 | WO1991006559A1 Use of polymerized immunoglobulin to reduce the incidence of false-positive responses in immunoassays |
05/16/1991 | WO1991006553A1 Type i transglutaminase dna |
05/16/1991 | WO1991006321A1 Use of honey as vaccine |
05/16/1991 | WO1991006319A1 Methods and compositions for promoting immunopotentiation |
05/16/1991 | WO1991006315A1 Anti-platelet monoclonal antibody |
05/16/1991 | WO1991006314A2 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
05/16/1991 | WO1991006311A1 Anti-viral material |
05/16/1991 | WO1991006306A1 Antivenoms and methods for making antivenoms |
05/16/1991 | WO1991004728A3 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome |
05/16/1991 | CA2071546A1 Anti-viral material |
05/16/1991 | CA2071478A1 Methods and compositions for promoting immunopotentiation |
05/15/1991 | EP0427399A1 Cancer marker and monoclonal antibodies specific therefor |
05/15/1991 | EP0426838A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
05/15/1991 | EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS |
05/15/1991 | CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
05/15/1991 | CA2029714A1 Antiidiotypic monoclonal antibodies |
05/14/1991 | WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | WO1991007493A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | WO1991007492A1 Monoclonal antibodies |
05/14/1991 | WO1991007482A1 Type-b rotavirus cultures and uses thereof |
05/14/1991 | WO1991007434A1 Control of milk secretion |
05/14/1991 | WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
05/14/1991 | US5015729 Proteins which are hormone inhibitors for follicle stimulating hormones but not luteinizing hormone, fertility agents for sheep |
05/14/1991 | US5015571 Polypeptide-induced monoclonal receptors to protein ligands |
05/14/1991 | US5015568 Quantitative analysis of antibodies and antigens for b-cells |
05/14/1991 | CA2068520A1 Type-b rotavirus cultures and uses thereof |
05/14/1991 | CA2068515A1 Control of milk secretion |
05/14/1991 | CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens |
05/14/1991 | CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
05/08/1991 | WO1991006649A1 Mouse antibody v-region gene fragment and preparation of chimera antibody by using said gene fragment |
05/08/1991 | WO1991006305A1 Oligomeric immunoglobulins |
05/08/1991 | EP0425665A1 Method for assaying chondrocalcine |
05/08/1991 | EP0425661A1 A new method for tapping the immunological repertoire |
05/08/1991 | EP0425549A1 Novel proteins, dna coding for said proteins, and their use |
05/08/1991 | CA2045150A1 Oligomeric immunoglobulins |
05/08/1991 | CA2044578A1 Mouse antibody v region gene fragments and method of chimeric antibody preparation using said gene fragments |
05/07/1991 | US5013720 SAP-6-Val proteins and methods |
05/07/1991 | US5013664 Common protein of Haemophilus influenzae type b identified by a monoclonal antibody |
05/07/1991 | US5013645 Immunological methods and materials for detection of tumor associated antigens |
05/07/1991 | US5013445 Liquid chromatography, porous gel solid phase, no adjustment of buffer solution pH |
05/07/1991 | CA1283856C Purification of immunoglobulin g |
05/04/1991 | WO1991006860A1 HYBRIDOMAS AND MONOCLONAL ANTIBODIES THEREFROM REACTIVE TOWARD ANTIGENS FROM $i(EDWARDSIELLA ICTALURI) |
05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/04/1991 | CA2072741A1 Hybridomas and monoclonal antibodies therefrom reactive toward antigens from edwardsiella ictaluri |
05/03/1991 | WO1991006857A1 Immunoassay of human thrombomodulin, and reagent and kit therefor |
05/03/1991 | CA2044629A1 Method for the immunological assay of human thrombomodulin, reagent therefor and kit therefor |
05/02/1991 | WO1991006009A1 N-acetylmuramidase m1 |
05/02/1991 | WO1991005876A1 Human cytomegalovirus-specific monoclonal antibody cocktail |
05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |
05/02/1991 | WO1991005862A1 cDNA FRAGMENT CODING THE ALPHA INTERFERON RECEPTOR GENE AND PROCESS FOR THE PREPARATION OF A CORRESPONDING PROTEIN |
05/02/1991 | WO1991005856A1 Chimeric monoclonal antibodies generated by trans-splicing |
05/02/1991 | WO1991005802A1 Osteogenic devices |
05/02/1991 | WO1991005800A1 ANTI-RhD HETEROANTIBODIES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
05/02/1991 | WO1991005795A1 Stem cell factor |
05/02/1991 | WO1991005567A1 Vaccins for protecting against infections by hiv virus, process for producing the same and their use as diagnostic and immunotherapy means |
05/02/1991 | WO1991004273A3 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
05/02/1991 | EP0424990A1 The manufacture and expression of large structural genes |
05/02/1991 | EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship. |
05/02/1991 | EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
05/02/1991 | DE4031283A1 New antibodies reactive with conjugates of nicergolin hydrolysis prods - used for immunoassay of non-metabolised nicergolin, also new conjugates and hybrid cell lines |
05/02/1991 | CA2042577A1 Osteogenic devices |
05/01/1991 | WO1991006573A1 Inhibitor of laminin neurite promoting activity |
05/01/1991 | WO1991006356A1 Method to identify analyte-binding ligands |
05/01/1991 | CA2072637A1 Method to identify analyte-binding ligands |
05/01/1991 | CA2066658A1 Inhibitor of laminin neurite promoting activity |
04/30/1991 | US5011920 Disialofucoganglioside immunogen and fucoganglioside monosialosyl Lea II |
04/30/1991 | US5011914 Purified ciliary neurotrophic factor |
04/30/1991 | US5011912 Calcium-dependent affinity for selected peptide terminal sequence |
04/30/1991 | US5011778 Medicament for blocking inflammatory responses |
04/30/1991 | US5011777 Vectors encoding brain derivable polypeptide factors |
04/30/1991 | US5011684 Administering monoclonal antibody to interleukin receptor |
04/30/1991 | CA2001756A1 New human lymphotoxin n-end deletion mutant |
04/30/1991 | CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
04/28/1991 | WO1991006572A1 Diagnosis of glomerulonephritis |
04/28/1991 | WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |